Cargando…
Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer
Epigenetic alterations by promoter DNA hypermethylation and gene silencing in cancer have been reported over the past few decades. DNA hypermethylation has great potential to serve as a screening marker, a prognostic marker, and a therapeutic surveillance marker in cancer clinics. Some bodily fluids...
Autores principales: | Yokoi, Keigo, Yamashita, Keishi, Watanabe, Masahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412321/ https://www.ncbi.nlm.nih.gov/pubmed/28358330 http://dx.doi.org/10.3390/ijms18040735 |
Ejemplares similares
-
Novel Multiplex MethyLight Protocol for Detection of DNA Methylation in Patient Tissues and Bodily Fluids
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2014) -
Prediction of onset of remnant gastric cancer by promoter DNA methylation of CDO1/HOPX/Reprimo/E-cadherin
por: Kojima, Keita, et al.
Publicado: (2019) -
Epigenetic biomarkers of promoter DNA methylation in the new era of cancer treatment
por: Yamashita, Keishi, et al.
Publicado: (2018) -
Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer
por: Kojima, Keita, et al.
Publicado: (2019) -
Detection of Chikungunya virus in bodily fluids: The INOVACHIK cohort study
por: Martins, Ezequias B., et al.
Publicado: (2022)